As some cancers are driven by gene translocations (e.g., Ewing sarcoma is driven by the reciprocal translocation between EWS gene and ETS transcription factor (Fli-1)), a research group aimed to detect circulating DNA fragments carrying this translocation breakpoint to assess tumor burden. The gene discussed is FLI1; the disease is neoplasm.